- sales@expolake.com
- +1-469-567-9589
Access a verified, campaign-ready database of thrombosis, hemostasis, hematology, vascular biology, and bleeding-disorder professionals attending and exhibiting at the 34th International Society on Thrombosis and Haemostasis (ISTH) Congress in Paris. The event brings together leading clinicians, researchers, scientists, laboratory specialists, pharmaceutical executives, biotech innovators, and healthcare decision-makers from more than 100 countries.
Whether you are planning pre-event meetings, launching targeted marketing campaigns, promoting diagnostic technologies, or expanding your presence in the hematology and thrombosis market, the ISTH 2026 attendee and exhibitor database provides direct access to the global community shaping the future of thrombosis and hemostasis research and treatment. The Congress features a large technical exhibition showcasing the latest diagnostics, therapeutics, laboratory technologies, and research solutions
Verified Attendees
Exhibiting Companies
Accuracy
Delivery Time
Verification Layers
The International Society on Thrombosis and Haemostasis (ISTH) Congress is widely regarded as the world’s leading scientific gathering dedicated to blood clotting, bleeding disorders, and vascular medicine. The 2026 edition will bring thousands of physicians, researchers, laboratory professionals, and healthcare innovators to Paris for five days of scientific advancement and global collaboration.
The congress serves as a platform for unveiling breakthrough discoveries in thrombosis, hemophilia, coagulation science, and emerging therapies. With participation from top academic institutions, healthcare organizations, and life science companies, ISTH 2026 remains one of the most influential events shaping the future of hematology worldwide.
Leading organizations across thrombosis, hemostasis, hemophilia, diagnostics, and life sciences showcase their innovations at ISTH 2026.
Global drug manufacturers presenting anticoagulants, clotting factor concentrates, hemophilia treatments, rare disease therapies, gene therapies, and late-stage hematology pipelines to physicians, researchers, and healthcare institutions.
Companies offering coagulation analyzers, hemostasis testing systems, laboratory instruments, reagents, biomarker assays, and advanced diagnostic solutions used in bleeding and clotting disorder management.
Biotech organizations developing next-generation therapies, genetic medicines, recombinant products, cell-based treatments, and precision medicine solutions targeting thrombosis and inherited bleeding disorders.
Research organizations supporting clinical trials, patient recruitment, data management, regulatory compliance, pharmacovigilance, and real-world evidence generation for hematology and vascular medicine sponsors.
Manufacturers of laboratory automation systems, sample processing equipment, research instruments, assay platforms, and scientific technologies used in academic and clinical laboratories.
Technology providers delivering clinical analytics, healthcare software, AI-powered research tools, digital patient monitoring, data management platforms, and decision-support solutions for healthcare professionals.
Leading physicians and clinical experts focused on thrombosis prevention, anticoagulation management, bleeding disorders, hemophilia treatment, and vascular health from hospitals, academic medical centers, and specialty clinics worldwide.
Principal investigators, translational researchers, laboratory scientists, and university faculty presenting breakthrough discoveries in coagulation science, platelet biology, vascular medicine, and blood disorder research.
Senior executives, medical affairs professionals, R&D directors, commercial leaders, and business development teams representing companies developing therapies for thrombosis, hemophilia, rare blood diseases, and related conditions.
Clinical laboratory managers, pathology specialists, coagulation testing professionals, and diagnostic experts evaluating new technologies, testing platforms, biomarkers, and laboratory solutions.
Clinical operations leaders, trial coordinators, regulatory affairs specialists, pharmacovigilance experts, and compliance professionals supporting global hematology and cardiovascular research programs.
Nurses, pharmacists, physician associates, transfusion medicine specialists, genetic counselors, and healthcare practitioners involved in the diagnosis, treatment, and long-term management of bleeding and clotting disorders.
The ISTH 2026 contact database contains comprehensive professional, organizational, and industry-specific data points designed for precise targeting across hematology, thrombosis, hemostasis, diagnostics, biotechnology, and pharmaceutical sectors.
Each record delivers valuable insights into attendee roles, clinical expertise, research focus, and company information, helping sales and marketing teams connect with the right decision-makers before, during, and after the congress.
These structured data fields enable highly targeted outreach campaigns based on specialty, institution type, job function, geographic region, research interests, and purchasing influence within the global thrombosis and hemostasis community.
Connect with verified hematologists, thrombosis specialists, hemophilia experts, laboratory professionals, clinical researchers, pharmaceutical executives, and biotechnology decision-makers actively participating in ISTH 2026.
Every contact record undergoes extensive validation processes, including email verification, professional profile cross-checking, and organizational confirmation to maximize data accuracy and campaign performance.
Leverage the database for email marketing, account-based marketing (ABM), event networking, appointment setting, business development outreach, and strategic partnership initiatives before and after ISTH 2026.
Access detailed contact records featuring job titles, specialties, institution types, seniority levels, geographic locations, company information, and other valuable firmographic insights for more personalized outreach.
Build targeted lists based on specialty, therapeutic focus, organization type, job function, research interests, geographic region, seniority, and attendee or exhibitor status to improve campaign relevance and response rates.
Receive structured data in easy-to-use formats compatible with major CRM, marketing automation, and sales engagement platforms, enabling your team to launch campaigns quickly and efficiently.
Get verified attendee and exhibitor contact lists from past and upcoming event editions worldwide. ExpoLake delivers accurate, segmented B2B contact data covering key decision-makers and exhibiting companies, so your outreach always reaches the right person at the right time.
Gain direct access to hematologists, thrombosis specialists, laboratory directors, pharmaceutical executives, biotechnology leaders, and healthcare professionals actively participating in ISTH 2026. Reach the people involved in clinical, research, purchasing, and partnership decisions.
Build awareness and schedule meetings before attendees arrive in Paris. Use targeted outreach campaigns to introduce your solutions, secure appointments, and create valuable opportunities ahead of the event.
ISTH attendees are highly engaged professionals seeking new research collaborations, technologies, therapies, and business partnerships. Connecting with them can significantly reduce prospecting time and improve conversion potential.
Identify and engage professionals across thrombosis, hemostasis, hemophilia, vascular medicine, diagnostics, and life sciences. Discover new market segments and strengthen your position within the global blood disorder ecosystem.
Maintain momentum after the event with structured attendee and exhibitor data. Follow up with prospects, nurture relationships, and continue conversations long after ISTH 2026 concludes.
Whether you're exhibiting, sponsoring, or attending, combining your event strategy with a targeted contact database helps maximize visibility, generate qualified leads, and create measurable business outcomes from your ISTH 2026 investment.
Every contact in the ExpoLake database goes through a structured, multi-step sourcing and verification process before it reaches your team. Here is how we build data you can trust.
Contacts are gathered from trade shows, global directories, e-books, newsletters, and digital publications spanning dozens of industries and regions.
Machine learning fills missing fields, appends firmographic data, and segments contacts by industry, role, company size, and intent signals — automatically.
Every record is cross-checked against our master database and validated via social platforms, public registries, and news sources to confirm authenticity.
Anomalies, duplicates, and stale entries are flagged using statistical models and eliminated. A final manual audit ensures the highest standard of data quality.
A/B-tested opt-in email sequences are deployed to capture and confirm explicit consent, fully aligned with GDPR, CAN-SPAM, and CASL compliance frameworks.
A final tele-verification call confirms all data fields. Only fully validated, consented records are released to the client — clean, compliant, and ready to use.
The database covers a broad range of professionals attending and exhibiting at ISTH 2026, including hematologists, thrombosis specialists, hemophilia experts, research scientists, laboratory directors, pharmaceutical executives, biotechnology leaders, clinical researchers, and healthcare professionals involved in blood disorder research and treatment.
Contacts span multiple sectors, including pharmaceuticals, biotechnology, molecular diagnostics, laboratory equipment, clinical research, healthcare technology, academic institutions, hospitals, and nonprofit healthcare organizations focused on thrombosis and hemostasis.
Yes. The database can be customized by country, region, continent, or specific target markets, helping organizations focus their outreach on the geographic areas most relevant to their business objectives.
Absolutely. The database is designed for organizations looking to engage healthcare professionals, researchers, laboratory specialists, pharmaceutical companies, biotechnology firms, and industry decision-makers participating in the global thrombosis and hemostasis market.
Yes. Depending on your requirements, attendee contacts, exhibitor contacts, or a combined database can be provided to support specific marketing, sales, partnership, or networking campaigns.
Available fields may include professional name, job title, company or institution name, business email, phone number (where available), location, industry classification, organization type, seniority level, and other relevant professional data points.
Pharmaceutical companies, biotech firms, diagnostic manufacturers, laboratory solution providers, CROs, healthcare technology vendors, recruiters, consultants, and medical service providers can all leverage the database to identify valuable business opportunities.
